featured
Tipifarnib in HNSCC With HRAS Mutations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
J. Clin. Oncol 2021 Mar 22;[EPub Ahead of Print], AL Ho, I Brana, R Haddad, J Bauman, K Bible, S Oosting, DJ Wong, MJ Ahn, V Boni, C Even, J Fayette, MJ Flor, K Harrington, SB Kim, L Licitra, I Nixon, NF Saba, S Hackenberg, P Specenier, F Worden, B Balsara, M Leoni, B Martell, C Scholz, A GualbertoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.